Perspectives for the management of febrile neutropenic patients with cancer in the 21st century
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sickles EA, 1975, Clinical presentation of infection in granulocytopenic patients, Arch Intern Med., 135, 715, 10.1001/archinte.1975.00330050089015
Chrischilles E, 2002, Factors associated with early termination of CHOP, and its association with overall survival among patients with intermediate‐grade non‐Hodgkin's lymphoma (NHL), Proc Am Soc Clin Oncol., 21, 385a
Hachem RY, 2003, Molecular patterns of decreased vancomycin‐resistant Enterococcus faecium (VREF) susceptibility to linezolid associated with clinical use
Allen U, 1986, The value of skin biopsies in febrile, neutropenic, immunocompromised children, Am J Dis Child., 140, 459
Talcott JA, 1988, The medical course of cancer patients with fever and neutropenia. Clinical identification of a low risk subgroup at presentation, Arch Intern Med., 148, 2561, 10.1001/archinte.1988.00380120031007
Yamamura D, 1997, Open randomized study of cefepime versus piperacillin‐gentamicin for treatment of febrile neutropenic cancer patients, Antimicrob Agents Chemother., 41, 1704, 10.1128/AAC.41.8.1704
Rolston KV, 1992, A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients, Arch Intern Med., 152, 283, 10.1001/archinte.1992.00400140037010
Centers for Disease Control and Prevention, 1995, Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC), MMWR Morb Mortal Wkly Rep., 44, 1
Gardenmbas‐Pain M, 1991, Home treatment of febrile neutropenia: an empirical oral antibiotic regimen, Ann Oncol., 2, 485, 10.1093/oxfordjournals.annonc.a057996
Goldstone AH, 1994, Early AmBisome in febrile neutropenia in patients with haematological disorders, Bone Marrow Transplant., 14, S15